Anti-cancer

Lapatinib

Also known as: Lapatinib Ditosylate

CAS No. 231277-92-2

A dual tyrosine kinase inhibitor (HER2/EGFR) used in oral oncology formulations for HER2-positive breast cancer.

Lapatinib is a targeted dual tyrosine kinase inhibitor oncology API manufactured by NovaAcura Biotech under strict GMP conditions. Full batch documentation and regulatory support are available for global oncology formulation partners.

Applications & Uses

A dual tyrosine kinase inhibitor (HER2/EGFR) used in oral oncology formulations for HER2-positive breast cancer.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch